on 7 Aug 2024
Last Applicant/ Owned by
POINT BIOPHARMA CORP.
22 St. Clair Ave East, Suite 1201Toronto
ONTARIO
CA
M4T2S3
Serial Number
2043695 filed on 4th Aug 2020
Correspondent Address
BORDEN LADNER GERVAIS LLP
World Exchange Plaza100 Queen Street, Suite 1300Ottawa
ONTARIO
CA
K1P1J9
Trademark usage description
pharmaceutical preparations for the diagnosis and treatment of cancer and tumors; pharmaceutical preparations for the diagnosis and treatment of oncol Read MoreVienna Information
27 . 5 . 1
Letters presenting a special form of writingLettres présentant un graphisme spécial
27 . 5 . 19
Letters overlappingLettres se chevauchant
27 . 5 . 8
Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.Lettres liées à un élément figuratif ou contenant un élément figuratif -- Note: Les lettres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet sont classées dans la division 27.3.
24 . 17 . 5
Mathematical signsSignes mathématiques
24 . 17 . 8
Infinity SymbolSigne de l'infini
11
2043695
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 22 on 7th Aug 2024 | Search Recorded |
Submitted for opposition 20 on 7th Aug 2024 | Examiner's First Report |
Submitted for opposition 48 on 30th Jan 2024 | Agent Changed |
Submitted for opposition 287 on 19th Apr 2022 | Pre-Assessment Letter Sent |
Submitted for opposition 30 on 4th Aug 2020 | Filed |
Submitted for opposition 1 on 4th Aug 2020 | Created |
Submitted for opposition 31 on 4th Aug 2020 | Formalized |